SCHEMBL3484043

SCHEMBL3484043

CCOC(=O)C(C)(C)Oc1ccccc1C(=O)c1ccc(CBr)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.48
PPARG P37231 4/20 0.48
FBP1 P09467 3/20 0.46
ELANE P08246 2/20 0.45
TSHR P16473 2/20 0.42
ABCB11 O95342 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR2A P28223 1/20 0.42
PMP22 Q01453 1/20 0.42
OPRK1 P41145 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ABCB1 P08183 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484969 0.89 PPARA (0.51) PPARAPPARGFBP1ELANETSHR
SCHEMBL3484028 0.84 FBP1 (0.47) PPARAPPARGFBP1TSHRABCB11
SCHEMBL3484192 0.82 PPARA (0.59) PPARAPPARGFBP1ELANETSHR
SCHEMBL3484819 0.81 FBP1 (0.47) PPARAPPARGFBP1TSHRABCB11
SCHEMBL31745119 0.79 FBP1 (0.54) PPARAPPARGFBP1TSHRABCB11
SCHEMBL3484510 0.79 PPARG (0.54) PPARAPPARGFBP1TSHRABCB11
SCHEMBL7017547 0.78 TSHR (0.62) TSHRCYP1A2CYP3A4CES2CES1
SCHEMBL4685610 0.78 FBP1 (0.53) PPARAPPARGFBP1TSHRABCB11
SCHEMBL11783788 0.78 FBP1 (0.53) PPARAPPARGFBP1ELANETSHR
SCHEMBL7017613 0.77 STS (0.56) CES2CES1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 PPARA 1045/4885PPARG 422/4885FBP1 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.